GlucoTrack (GCTK) EBITDA (2003 - 2025)
GlucoTrack (GCTK) EBITDA from Dec 31, 2003 to Dec 31, 2025. The TTM GlucoTrack (GCTK) EBITDA is -$16M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
GlucoTrack (GCTK) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +10.61% |
| 3 Years TTM | +53.82% |
| 5 Years TTM | +39.03% |
| 10 Years TTM | +13.29% |
| All Time TTM | +21.06% |
Annual EBITDA change of GlucoTrack (GCTK)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$16M | +10.61% |
| 2024 | -$15M | +104.65% |
| 2023 | -$7.09M | +60.77% |
| 2022 | -$4.41M | +9.98% |
| 2021 | -$4.01M | +29.35% |
| 2020 | -$3.10M | -187.08% |
| 2019 | $3.56M | -154.94% |
| 2018 | -$6.48M | -160.90% |
| 2017 | $11M | -290.00% |
| 2016 | -$5.60M | +21.48% |
| 2015 | -$4.61M | +29.13% |
| 2014 | -$3.57M | +19.40% |
| 2013 | -$2.99M | +8.73% |
| 2012 | -$2.75M | +19.05% |
| 2011 | -$2.31M | +72.39% |
| 2010 | -$1.34M | +16.52% |
| 2009 | -$1.15M | -24.84% |
| 2008 | -$1.53M | -3.77% |
| 2007 | -$1.59M | +24.22% |
| 2006 | -$1.28M | +20.75% |
| 2005 | -$1.06M | +265.52% |
| 2004 | -$290K | -17.14% |
| 2003 | -$350K | N/A |
Comparison GlucoTrack (GCTK) five years EBITDA CAGR with competitors
GlucoTrack (GCTK) five years EBITDA CAGR is 38.94%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| POCI | Precision Optics Corp Inc | 111.37% | +186.03% |
| NYXH | Nyxoah SA | 45.05% | +15.70% |
| STXS | Stereotaxis Inc | 28.84% | -25.93% |
| ZTEK | Zentek Ltd | 26.96% | -30.76% |
| RGNT | Regentis Biomaterials Ltd | 26.85% | -31.05% |
| MMSI | Merit Medical Systems Inc | 24.73% | -36.48% |
| BLFS | Biolife Solutions Inc | 22.17% | -43.07% |
| ISRG | Intuitive Surgical Inc | 21.90% | -43.74% |
| RGEN | Repligen Corp | 15.86% | -59.28% |
| RMD | Resmed Inc | 15.14% | -61.10% |
| ALC | Alcon Inc | 14.84% | -61.88% |
| LMAT | Lemaitre Vascular Inc | 14.82% | -61.93% |
| PDEX | Pro-Dex Inc (co) | 13.53% | -65.26% |
| ANGO | Angiodynamic Inc | 12.62% | -67.58% |
| MBOT | Microbot Medical Inc | 11.58% | -70.25% |
| STVN | Stevanato Group Spa | 9.34% | -76.02% |
| COO | Cooper Companies Inc | 7.73% | -80.14% |
| NXGL | Nexgel Inc | 7.05% | -81.90% |
| ATR | Aptargroup Inc | 6.79% | -82.55% |
| PLSE | Pulse Biosciences Inc | 6.69% | -82.81% |
| WST | West Pharmaceutical Services Inc | 6.51% | -83.28% |
| ICUI | ICU Medical Inc | 5.71% | -85.34% |
| ALGN | Align Technology Inc | 4.82% | -87.61% |
| EKSO | Ekso Bionics Holdings Inc | 4.60% | -88.20% |
| BDX | Becton Dickinson & Company | 4.54% | -88.34% |
| NVST | Envista Holdings Corp | 4.52% | -88.39% |